Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 1.00 |
| ▸ | BCHE | P06276 | 12/20 | 0.60 |
| ▸ | ACHE | P22303 | 5/20 | 0.60 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | SNCA | P37840 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29406737 | 1.00 | MEN1 (1.00) | MEN1MAPK1KMT2ATDP1L3MBTL1 | |
| SCHEMBL11143818 | 0.95 | MEN1 (0.90) | MEN1MAPK1KMT2ATDP1L3MBTL1 | |
| SCHEMBL13019550 | 0.94 | MEN1 (0.88) | MEN1MAPK1KMT2ATDP1L3MBTL1 | |
| SCHEMBL14476957 | 0.91 | MAPK1 (0.83) | MEN1MAPK1KMT2ATDP1L3MBTL1 | |
| SCHEMBL9009237 | 0.91 | MEN1 (0.83) | MEN1MAPK1KMT2ATDP1L3MBTL1 | |
| SCHEMBL9100414 | 0.91 | MEN1 (0.83) | MEN1MAPK1KMT2ATDP1L3MBTL1 | |
| SCHEMBL15963115 | 0.90 | MEN1 (0.81) | MEN1MAPK1KMT2ATDP1L3MBTL1 | |
| SCHEMBL9009183 | 0.89 | MAPK1 (0.81) | MEN1MAPK1KMT2ATDP1L3MBTL1 | |
| SCHEMBL10827176 | 0.88 | KMT2A (0.78) | MEN1MAPK1KMT2ATDP1L3MBTL1 | |
| SCHEMBL7194601 | 0.87 | MEN1 (0.78) | MEN1MAPK1KMT2ATDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 736 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119978604-A | Polymer film composition, polymer film, and laminate | 福斯特(滁州)新材料有限公司 | 2025-05-13 | — | — | CN | claimed |
| CN-112013989-B | Lower critical temperature indicating device | 江苏集萃智能液晶科技有限公司 | 2025-04-04 | — | — | CN | claimed |
| EP-4345131-A1 | CATIONICALLY CURABLE ADHESIVE COMPOSITION WITH DEFINED COLOURING IN THE CURED STATE | tesa SE (DE) | 2024-04-03 | — | — | EP | claimed |
| WO-2023132551-A1 | SAND FOR DIAGNOSING STATE OF ANIMAL URINE, METHOD FOR MANUFACTURING SAME, AND URINE STATE DIAGNOSIS METHOD USING SAME | 주식회사 퓨쳐바이오웍스 | 2023-07-13 | — | — | WO | claimed |
| WO-2023116088-A1 | THERMOCHROMISM INDICATOR | 江苏集萃智能液晶科技有限公司 | 2023-06-29 | — | — | WO | claimed |
| US-11435293-B2 | Dual-function heat indicator and method of manufacture | TEMPTIME CORPORATION (US) | 2022-09-06 | — | — | US | claimed |
| US-20220235019-A1 | NOVEL IMPROVED METHOD FOR SYNTHESIZING DIAMINOPHENOTHIAZINE COMPOUNDS | AGRAWAL ACHAL NARENDRAKUMAR (IN) | 2022-07-28 | — | — | US | claimed |
| CN-111276035-B | Temperature indicating label | 苏州和萃新材料有限公司 | 2022-04-12 | — | — | CN | claimed |
| US-7956334-B2 | Radiation dosimeter for fluid very small substances, and method of measuring radiation dose | SCHOOL CORPORATION, AZABU UNIVERSITY MEDICINE EDUCATIONAL INSTITUTION (JP) | 2011-06-07 | — | — | US | claimed |
| US-20090045352-A1 | Radiation Dosimeter For Fluid Very Small Substances, And Method Of Measuring Radiation Dose | SCHOOL CORPORATION, AZABU UNIVERSITY MEDICINE EDUCATIONAL INSTITUTION (JP) | 2009-02-19 | — | — | US | claimed |
| EP-0714786-B1 | New microcapsules comprising as solvent a terpene derivative or an abietic acid derivative, notably for chemical copy papers and messure sensitive papers coated with such microcapsules | COPIGRAPH (FR) | 2000-03-22 | — | — | EP | claimed |
| EP-0697293-B1 | New organic solvent for microcapsules useful notably for pressure-sensitive copy paper and pressure-sensitive copy coated with such microcapsules | COPIGRAPH (FR) | 1998-09-09 | — | — | EP | claimed |
| EP-0245505-B2 | TERMINAL-MODIFIED BLOCK COPOLYMER AND COMPOSITION CONTAINING SAID COPOLYMER | ASAHI CHEMICAL IND (JP) | 1996-08-14 | — | — | EP | claimed |
| EP-0714786-A1 | New microcapsules comprising as solvent a terpene derivative or an abietic acid derivative, notably for chemical copy papers and messure sensitive papers coated with such microcapsules | COPIGRAPH (FR) | 1996-06-05 | — | — | EP | claimed |
| EP-0697293-A1 | New organic solvent for microcapsules useful notably for pressure-sensitive copy paper and pressure-sensitive copy coated with such microcapsules | COPIGRAPH (FR) | 1996-02-21 | — | — | EP | claimed |
| EP-0159874-B1 | PREVENTION OF SPOTTING IN THERMAL IMAGING COMPOSITIONS | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-07-24 | — | — | EP | claimed |
| EP-0245505-A1 | TERMINAL-MODIFIED BLOCK COPOLYMER AND COMPOSITION CONTAINING SAID COPOLYMER | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1987-11-19 | — | — | EP | claimed |
| US-3940275-A | Record material and marking liquid | NCR CORPORATION (US) | 1976-02-24 | — | — | US | claimed |
| JP-7266693-A | — | — | None | — | — | JP | disclosed |
| US-3940275-A | Record material and marking liquid | NCR CORPORATION (US) | 1976-02-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220235019-A1 | NOVEL IMPROVED METHOD FOR SYNTHESIZING DIAMINOPHENOTHIAZINE COMPOUNDS | QDPR, DHPS, MPST | MEN1 543/4885MAPK1 796/4885KMT2A 663/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.